All data are based on the daily closing price as of December 24, 2024
e
Eiken Chemical
4549.TSE
14.08 USD
-0.12
-0.85%
Overview
Last close
14.08 usd
Market cap
487.24M usd
52 week high
17.02 usd
52 week low
8.87 usd
Target price
14.01 usd
Valuation
P/E
33.5428
Forward P/E
N/A
Price/Sales
1.93
Price/Book Value
1.6498
Enterprise Value
423.31M usd
EV/Revenue
1.6818
EV/EBITDA
12.1123
Key financials
Revenue TTM
251.70M usd
Gross Profit TTM
130.61M usd
EBITDA TTM
32.96M usd
Earnings per Share
0.42 usd
Dividend
0.33 usd
Total assets
440.70M usd
Net debt
-70.49M usd
About
Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.